title: Postnatal growth after intrauterine growth restriction alters central leptin signal and energy homeostasis.
abstract: Intrauterine growth restriction (IUGR) is closely linked with metabolic diseases, appetite disorders and obesity at adulthood. Leptin, a major adipokine secreted by adipose tissue, circulates in direct proportion to body fat stores, enters the brain and regulates food intake and energy expenditure. Deficient leptin neuronal signalling favours weight gain by affecting central homeostatic circuitry. The aim of this study was to determine if leptin resistance was programmed by perinatal nutritional environment and to decipher potential cellular mechanisms underneath.We clearly demonstrated that 5 months old IUGR rats develop a decrease of leptin sentivity, characterized by no significant reduction of food intake following an intraperitoneal injection of leptin. Apart from the resistance to leptin injection, results obtained from IUGR rats submitted to rapid catch-up growth differed from those of IUGR rats with no catch-up since we observed, for the first group only, fat accumulation, increased appetite for food rich in fat and increased leptin synthesis. Centrally, the leptin resistant state of both groups was associated with a complex and not always similar changes in leptin receptor signalling steps. Leptin resistance in IUGR rats submitted to rapid catch-up was associated with alteration in AKT and mTOR pathways. Alternatively, in IUGR rats with no catch-up, leptin resistance was associated with low hypothalamic expression of LepRa and LepRb. This study reveals leptin resistance as an early marker of metabolic disorders that appears before any evidence of body weight increase in IUGR rats but whose mechanisms could depend of nutritional environment of the perinatal period.
authors.affiliation: UMR 1280 Physiologie des Adaptations Nutritionnelles, Université de Nantes Atlantique, Nantes, France.
authors.forename: Bérengère
authors.initials: B
authors.lastname: Coupé
authors.forename: Isabelle
authors.initials: I
authors.lastname: Grit
authors.forename: Philippe
authors.initials: P
authors.lastname: Hulin
authors.forename: Gwenaëlle
authors.initials: G
authors.lastname: Randuineau
authors.forename: Patricia
authors.initials: P
authors.lastname: Parnet
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002490:Central Nervous System / Q000378:metabolism* / Q000502:physiology; D004351:Drug Resistance / Q000235:genetics / Q000502:physiology; D004734:Energy Metabolism / Q000235:genetics / Q000502:physiology*; D005260:Female; D005317:Fetal Growth Retardation / Q000378:metabolism* / Q000503:physiopathology / Q000534:rehabilitation*; D018507:Gene Expression Regulation, Developmental; D048788:Growth and Development / Q000235:genetics / Q000502:physiology*; D006706:Homeostasis / Q000235:genetics / Q000502:physiology; D020738:Leptin / Q000235:genetics / Q000378:metabolism*; D008297:Male; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D054411:Receptors, Leptin / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology
chemical_list: D020738:Leptin; D054411:Receptors, Leptin